|
animals |
15 |
|
oxidative stress |
13 |
|
mice |
11 |
|
anoxia - metabolism |
9 |
|
calcium - metabolism |
9 |
|
embryonic stem cells |
9 |
|
hypoxia |
9 |
|
inflammation |
9 |
|
humans |
8 |
|
intermittent hypoxia |
8 |
|
male |
8 |
|
melatonin |
8 |
|
up-regulation |
8 |
|
antigens, differentiation - biosynthesis |
7 |
|
antimutagenic agents - pharmacology |
7 |
|
biology |
7 |
|
cardiomyocytes |
7 |
|
cell differentiation |
7 |
|
cell differentiation - drug effects |
7 |
|
cells, cultured |
7 |
|
chronic periodontitis |
7 |
|
cobalt - pharmacology |
7 |
|
cytokines - biosynthesis |
7 |
|
embryonic stem cells - cytology |
7 |
|
embryonic stem cells - cytology - metabolism |
7 |
|
heart - physiology |
7 |
|
homeostasis - drug effects |
7 |
|
hypoxia inducible factor-1α |
7 |
|
hypoxia-inducible factor 1, alpha subunit - biosynthesis |
7 |
|
models, biological |
7 |
|
myocardium - cytology - metabolism |
7 |
|
myocardium - metabolism |
7 |
|
nitric oxide |
7 |
|
organ specificity - drug effects |
7 |
|
rna, messenger - metabolism |
7 |
|
sarcoplasmic reticulum function |
7 |
|
signal transduction |
7 |
|
troponin t - biosynthesis |
7 |
|
vascular endothelial growth factor a - metabolism |
7 |
|
apolipoprotein a-i - metabolism |
6 |
|
carbon tetrachloride |
6 |
|
cardiovascular disease |
6 |
|
cell hypoxia |
6 |
|
cellular neuroscience |
6 |
|
disease models, animal |
6 |
|
endocrinology |
6 |
|
fibrosis |
6 |
|
liver injury |
6 |
|
lycium barbarum polysaccharides |
6 |
|
medical sciences |
6 |
|
molecular neuroscience |
6 |
|
neurogenesis |
6 |
|
neuroscience |
6 |
|
pluripotent stem cells - cytology |
6 |
|
rats |
6 |
|
rats, sprague-dawley |
6 |
|
vascular endothelial growth factor a |
6 |
|
alanine transaminase - blood |
5 |
|
alzheimer's disease |
5 |
|
anti-inflammatory agents - isolation & purification - pharmacology |
5 |
|
antioxidants - isolation & purification - pharmacology |
5 |
|
cytochrome p-450 cyp2e1 - antagonists & inhibitors - metabolism |
5 |
|
cytokines - genetics - metabolism |
5 |
|
cytoprotection |
5 |
|
drug-induced liver injury - etiology - genetics - metabolism - pathology - prevention & control |
5 |
|
drugs, chinese herbal - isolation & purification - pharmacology |
5 |
|
enzyme inhibitors - pharmacology |
5 |
|
female |
5 |
|
gene expression regulation, enzymologic - drug effects |
5 |
|
immunohistochemistry |
5 |
|
inflammation mediators - metabolism |
5 |
|
lipid peroxidation - drug effects |
5 |
|
liver |
5 |
|
liver - drug effects - metabolism - pathology |
5 |
|
lycium - chemistry |
5 |
|
mice, inbred c57bl |
5 |
|
necrosis |
5 |
|
nf-kappa b - metabolism |
5 |
|
nitric oxide - metabolism |
5 |
|
non-alcoholic fatty liver disease |
5 |
|
nuclear factor kappa-b |
5 |
|
oxidative stress - drug effects |
5 |
|
plants, medicinal |
5 |
|
toll-like receptor 4 |
5 |
|
alzheimer’s disease |
4 |
|
anxiety |
4 |
|
apoptosis |
4 |
|
chronic disease |
4 |
|
chronic periodontitis - metabolism - pathology |
4 |
|
cluster of differentiation |
4 |
|
contraction |
4 |
|
endothelial cells - metabolism - pathology |
4 |
|
endothelial function |
4 |
|
endothelial nitric oxide synthase |
4 |
|
epithelial cells - metabolism - pathology |
4 |
|
fibroblasts |
4 |
|
hippocampus - drug effects - metabolism - pathology |
4 |
|
hypoxia-inducible factor 1-α subunit |
4 |
|
hypoxia-inducible factor 1α subunit |
4 |
|
keratinocytes |
4 |
|
lipid peroxidation |
4 |
|
lipopolysaccharides |
4 |
|
lymphocyte antigen 96 |
4 |
|
necroinflammation |
4 |
|
nitric oxide synthases |
4 |
|
nuclear factor κb |
4 |
|
obesity |
4 |
|
reverse transcriptase polymerase chain reaction |
4 |
|
s-allylmercaptocysteine |
4 |
|
sleep apnea |
4 |
|
time factors |
4 |
|
tumor necrosis factor-alpha |
4 |
|
adhesion molecules |
3 |
|
adrenomedullin - genetics - metabolism |
3 |
|
aged |
3 |
|
aging - genetics - metabolism |
3 |
|
anoxia - genetics - metabolism |
3 |
|
anoxia - genetics - metabolism - pathology |
3 |
|
anoxia - metabolism - pathology - prevention & control |
3 |
|
anti-oxidant |
3 |
|
antioxidant enzymes |
3 |
|
autophagy |
3 |
|
calcitonin receptor-like protein |
3 |
|
carotid body |
3 |
|
carotid body - metabolism |
3 |
|
caveolin-1 |
3 |
|
cell biology |
3 |
|
chronic aerobic exercise |
3 |
|
chronic hypoxia |
3 |
|
chronic intermittent hypoxia |
3 |
|
deep brain stimulation |
3 |
|
dementia |
3 |
|
dna methylation |
3 |
|
dysfunction |
3 |
|
electrophoresis |
3 |
|
elevated plus maze |
3 |
|
endothelin-1 - metabolism |
3 |
|
gene expression regulation, developmental |
3 |
|
hippocampus |
3 |
|
home cage emergence test |
3 |
|
host-microbial interactions |
3 |
|
hypertension |
3 |
|
hypoxia-inducible factor 1 - biosynthesis - genetics |
3 |
|
induced pluripotent stem cells |
3 |
|
inflammation mediators - therapeutic use |
3 |
|
learning and memory |
3 |
|
lung - metabolism - pathology |
3 |
|
lung injury |
3 |
|
major depressive disorder |
3 |
|
medial prefrontal cortex |
3 |
|
melatonin - administration & dosage - therapeutic use |
3 |
|
memory |
3 |
|
mesenchymal stem cells |
3 |
|
mitochondrial dysfunction |
3 |
|
mixed function oxygenases - genetics |
3 |
|
monoaminergic |
3 |
|
morphology |
3 |
|
multienzyme complexes - genetics |
3 |
|
nafld |
3 |
|
neural stem cells |
3 |
|
neuroanatomy |
3 |
|
neuroblastoma cells |
3 |
|
neurodegenerative disease |
3 |
|
neuroepigenetics |
3 |
|
neuromodulation |
3 |
|
neuronal nitric oxide synthase |
3 |
|
neuroplasticity |
3 |
|
neuroprotective agents - administration & dosage - therapeutic use |
3 |
|
neurotransmission |
3 |
|
periodontal disease |
3 |
|
periodontics |
3 |
|
periodontium-gingiva |
3 |
|
polyribosomes - metabolism |
3 |
|
preclinical |
3 |
|
proinflammatory cytokines |
3 |
|
protein precursors - genetics |
3 |
|
radioimmunoassay |
3 |
|
rd10 |
3 |
|
receptors, calcitonin - genetics |
3 |
|
retinal degeneration |
3 |
|
rna, messenger - genetics |
3 |
|
rna, messenger - genetics - metabolism |
3 |
|
stem cell therapy |
3 |
|
stem cell transplantation |
3 |
|
stem cells |
3 |
|
subcallosal cingulate |
3 |
|
transcription factors - genetics - metabolism |
3 |
|
treatment-resistant depression |
3 |
|
visual cortex |
3 |
|
xenopus proteins |
3 |
|
young |
3 |
|
5-lipoxygenase |
2 |
|
acidosis, respiratory - drug therapy - metabolism |
2 |
|
actins - metabolism |
2 |
|
acute liver injury |
2 |
|
adaptation, physiological |
2 |
|
adaptation, physiological - physiology |
2 |
|
adenylate cyclase - physiology |
2 |
|
aerobic exercise |
2 |
|
aging |
2 |
|
alanine transaminase - metabolism |
2 |
|
amyloid beta-peptides - metabolism |
2 |
|
anoxia - drug therapy - metabolism - pathology |
2 |
|
anoxia - etiology - physiopathology |
2 |
|
anoxia - genetics - physiopathology |
2 |
|
anoxia - metabolism - pathology |
2 |
|
anoxia - physiopathology |
2 |
|
anti-inflammation |
2 |
|
anti-inflammatory agents - therapeutic use |
2 |
|
anti-inflammatory agents, non-steroidal |
2 |
|
anti-neuroinflammatory |
2 |
|
antidepressant |
2 |
|
antioxidants |
2 |
|
arginine - pharmacology |
2 |
|
aspartic acid endopeptidases |
2 |
|
autophagosome |
2 |
|
base sequence |
2 |
|
basic helix-loop-helix transcription factors |
2 |
|
basic helix-loop-helix transcription factors - genetics - metabolism |
2 |
|
beta-site app cleavage enzyme |
2 |
|
blotting, western - methods |
2 |
|
carbon tetrachloride (ccl 4) |
2 |
|
cardiac hypertrophy |
2 |
|
cardioprotection |
2 |
|
cardiotonic agents |
2 |
|
cardiotonic agents - pharmacology |
2 |
|
cardiovascular |
2 |
|
cardiovascular diseases - prevention & control |
2 |
|
carotid arteries - metabolism |
2 |
|
carotid body - cytology - drug effects - metabolism |
2 |
|
carotid body - drug effects - metabolism |
2 |
|
carotid body - drug effects - physiopathology |
2 |
|
carotid body - metabolism - pathology |
2 |
|
carotid body - physiopathology |
2 |
|
carotid body, hypoxia, protein expression |
2 |
|
carotid chemoreceptor |
2 |
|
catalase |
2 |
|
catechin - analogs & derivatives - therapeutic use |
2 |
|
cellular injury |
2 |
|
cerebellar ataxia |
2 |
|
chemoreceptor |
2 |
|
chemoreceptor cells - drug effects |
2 |
|
chemoreceptor cells - drug effects - physiopathology |
2 |
|
chemoreceptor cells - metabolism |
2 |
|
chemoreceptor cells - physiology |
2 |
|
chemoreceptors, carotid body |
2 |
|
cholera toxin - pharmacology |
2 |
|
chronic liver injury |
2 |
|
circadian |
2 |
|
circadian rhythm - physiology |
2 |
|
collagen |
2 |
|
collagen type i - metabolism |
2 |
|
control of breathing, hypoxia, carotid body |
2 |
|
cyclic amp - metabolism |
2 |
|
cyclooxygenase |
2 |
|
cyclooxygenase 2 inhibitors - metabolism |
2 |
|
depression |
2 |
|
disease progression |
2 |
|
dna, complementary - genetics |
2 |
|
drug-induced liver injury - drug therapy - metabolism |
2 |
|
egcg |
2 |
|
electric stimulation |
2 |
|
electrodes |
2 |
|
electrophoretic mobility shift assay - methods |
2 |
|
electrophysiology |
2 |
|
electrophysiology - methods |
2 |
|
endothelin |
2 |
|
endothelin receptor |
2 |
|
endothelin-1 - genetics - metabolism |
2 |
|
endothelin-1 - metabolism - pharmacology |
2 |
|
endothelin-1 - metabolism - physiology |
2 |
|
epigallocatechin gallate (egcg) |
2 |
|
epigallocatechin-3-gallate (egcg) |
2 |
|
erythropoietin |
2 |
|
erythropoietin - metabolism |
2 |
|
erythropoietin - metabolism - physiology |
2 |
|
et-1 |
2 |
|
eta receptors |
2 |
|
flavonoids - pharmacology |
2 |
|
forskolin - pharmacology |
2 |
|
free radical scavengers - metabolism |
2 |
|
fura-2 - metabolism |
2 |
|
g protein |
2 |
|
gene expression |
2 |
|
gene expression regulation |
2 |
|
glomus cell |
2 |
|
glutathone peroxidase |
2 |
|
gtp-binding protein alpha subunits, gs - physiology |
2 |
|
heart ventricles |
2 |
|
hericium erinaceus |
2 |
|
hif |
2 |
|
hypercapnia |
2 |
|
hypercapnia - drug therapy - metabolism |
2 |
|
hypercapnia - metabolism |
2 |
|
hypoxia, carotid body, hif-1α, vegf |
2 |
|
hypoxia-inducible factor |
2 |
|
hypoxia-inducible factor 1 - genetics - physiology |
2 |
|
hypoxia-inducible factor 1, alpha subunit |
2 |
|
hypoxia-inducible factor 1, alpha subunit - genetics - metabolism |
2 |
|
hypoxia-inducible factor 1, alpha subunit - metabolism |
2 |
|
in situ hybridization |
2 |
|
infection and periodontics |
2 |
|
interleukin |
2 |
|
intracellular calcium |
2 |
|
intracellular membranes - metabolism |
2 |
|
isoproterenol - pharmacology |
2 |
|
isothiuronium - analogs & derivatives - pharmacology |
2 |
|
iype i cells |
2 |
|
l-arginine |
2 |
|
l-name |
2 |
|
lion’s mane mushroom |
2 |
|
liver - chemistry - enzymology |
2 |
|
liver - physiopathology |
2 |
|
liver cirrhosis - drug therapy - metabolism |
2 |
|
liver cirrhosis - enzymology |
2 |
|
liver fibrosis |
2 |
|
liver inflammation |
2 |
|
lysosomal membrane |
2 |
|
mammals, rat |
2 |
|
matrix metalloproteinases - metabolism |
2 |
|
mediators, hif-1α |
2 |
|
mediators, vegf |
2 |
|
melatonin - analogs & derivatives - antagonists & inhibitors - pharmacology - physiology |
2 |
|
melatonin - analogs & derivatives - pharmacology - physiology |
2 |
|
melatonin - pharmacology - therapeutic use |
2 |
|
melatonin receptors |
2 |
|
mice, inbred icr |
2 |
|
mitosis - physiology |
2 |
|
models, animal |
2 |
|
models, neurological |
2 |
|
mood disorders |
2 |
|
motor deficits |
2 |
|
myocardium - metabolism - pathology |
2 |
|
neuroprotection |
2 |
|
nf-kappa b - analysis |
2 |
|
ng-nitroarginine methyl ester - pharmacology |
2 |
|
nitric oxide - metabolism - physiology |
2 |
|
nitric oxide - physiology |
2 |
|
nitric oxide synthase |
2 |
|
nitric oxide synthase - antagonists & inhibitors - metabolism |
2 |
|
nitric oxide synthase - genetics - metabolism |
2 |
|
nitric oxide synthase type ii |
2 |
|
nitric oxide synthase type ii - analysis - antagonists & inhibitors - genetics |
2 |
|
nitric oxide synthase type ii - genetics - metabolism |
2 |
|
nitric oxide synthase type ii - metabolism |
2 |
|
nitric oxide synthase type iii - analysis - genetics - metabolism |
2 |
|
oxygen - metabolism |
2 |
|
ph |
2 |
|
phenols - pharmacology |
2 |
|
polyphenols |
2 |
|
procollagen - genetics |
2 |
|
prostaglandin |
2 |
|
protein isoforms - physiology |
2 |
|
random allocation |
2 |
|
reactive oxygen species |
2 |
|
receptor, endothelin a |
2 |
|
receptor, melatonin, mt1 - antagonists & inhibitors - genetics - metabolism |
2 |
|
receptor, melatonin, mt2 - antagonists & inhibitors - genetics - metabolism |
2 |
|
receptors, adrenergic, beta - metabolism |
2 |
|
receptors, cytokine - genetics - metabolism |
2 |
|
receptors, endothelin - genetics - metabolism |
2 |
|
receptors, erythropoietin - metabolism |
2 |
|
receptors, melatonin - antagonists & inhibitors - drug effects |
2 |
|
receptors, melatonin - antagonists & inhibitors - metabolism |
2 |
|
receptors, melatonin - drug effects - physiology |
2 |
|
receptors, vegf |
2 |
|
reference values |
2 |
|
respiration |
2 |
|
respiration - drug effects |
2 |
|
rna, messenger - analysis |
2 |
|
sleep apnea syndromes - metabolism - pathology - physiopathology |
2 |
|
smt |
2 |
|
sodium fluoride - pharmacology |
2 |
|
superoxide dismutase |
2 |
|
tea - chemistry |
2 |
|
tetrahydronaphthalenes - pharmacology |
2 |
|
tissue inhibitor of metalloproteinases - metabolism |
2 |
|
transcription factor ap-1 - analysis |
2 |
|
transcription factors - metabolism - physiology |
2 |
|
transcription factors - physiology |
2 |
|
transforming growth factor beta1 - genetics |
2 |
|
transforming growth factor beta1 - metabolism |
2 |
|
tryptamines - pharmacology |
2 |
|
tumor necrosis factor |
2 |
|
tumor necrosis factor-alpha - metabolism |
2 |
|
type-i cell |
2 |
|
type-i cells |
2 |
|
tyrosine - analogs & derivatives - metabolism |
2 |
|
tyrosine 3-monooxygenase - genetics - metabolism |
2 |
|
up-regulation - drug effects |
2 |
|
up-regulation - physiology |
2 |
|
vascular endothelial growth factor a - genetics - metabolism |
2 |
|
vascular endothelial growth factor a - metabolism - physiology |
2 |
|
vegf |
2 |
|
β-amyloid |
2 |
|
β-amyloid precursor protein |
2 |
|
2-amino-5-phosphonovalerate - pharmacology |
1 |
|
3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-isomer - pharmacology |
1 |
|
6-cyano-7-nitroquinoxaline-2,3-dione |
1 |
|
acute intermittent hypoxia |
1 |
|
adenosine diphosphate ribose - metabolism |
1 |
|
adenylate cyclase - metabolism |
1 |
|
adenylyl cyclase |
1 |
|
adrenergic beta-agonists - pharmacology |
1 |
|
age factors |
1 |
|
amiloride |
1 |
|
angiotensin |
1 |
|
angiotensin ii |
1 |
|
angiotensin ii - pharmacology |
1 |
|
angiotensin ii receptor |
1 |
|
angiotensin iv |
1 |
|
angiotensin iv receptor |
1 |
|
angiotensin receptor antagonists |
1 |
|
angiotensinogen |
1 |
|
angiotensinogen - genetics - metabolism |
1 |
|
animals, newborn |
1 |
|
animals, newborn - physiology |
1 |
|
anoxia |
1 |
|
anoxic depolarization |
1 |
|
antioxidant |
1 |
|
apneusis |
1 |
|
at 1a |
1 |
|
at 1b |
1 |
|
at1 receptor |
1 |
|
axons - physiology - ultrastructure |
1 |
|
biotin - analogs & derivatives |
1 |
|
bk channel |
1 |
|
body temperature - physiology |
1 |
|
brain |
1 |
|
brain ischemia - metabolism - pathology |
1 |
|
brain mapping |
1 |
|
brain stem - anatomy & histology - physiology |
1 |
|
brain stem - cytology - physiology |
1 |
|
brain stem - physiology |
1 |
|
ca1 |
1 |
|
ca2+ channel |
1 |
|
caffeine - pharmacology |
1 |
|
calcium |
1 |
|
calcium - analysis - metabolism |
1 |
|
calcium channels - metabolism |
1 |
|
calcium channels, l-type - metabolism |
1 |
|
calcium current |
1 |
|
calcium signaling - drug effects |
1 |
|
calcium-adenosine-triphosphatase |
1 |
|
calcium-transporting atpases - biosynthesis - drug effects |
1 |
|
camp |
1 |
|
captopril |
1 |
|
carbachol |
1 |
|
carbon dioxide - analysis - blood - pharmacology |
1 |
|
carbon dioxide, response |
1 |
|
carbon monoxide - toxicity |
1 |
|
cardiomegaly - physiopathology |
1 |
|
cardiomyocyte |
1 |
|
cardiorespiratory |
1 |
|
cardiotonic agents - therapeutic use |
1 |
|
cardiovascular diseases - epidemiology - prevention & control |
1 |
|
carotid body - metabolism - pathology - physiopathology |
1 |
|
cats |
1 |
|
central nervous system stimulants - pharmacology |
1 |
|
cgmp pathway |
1 |
|
chemoreceptor cells - drug effects - physiology |
1 |
|
chemoreceptors, central |
1 |
|
china - epidemiology |
1 |
|
co2 response |
1 |
|
co2 response, newborn rat |
1 |
|
control of breathing |
1 |
|
control of breathing, central chemosensitivity |
1 |
|
control of breathing, central neuronal activity |
1 |
|
control of breathing, central rhythm generation |
1 |
|
control of breathing, hypoxic response |
1 |
|
control of breathing, medullary neurons |
1 |
|
control of breathing, nmda receptors |
1 |
|
control of breathing, pneumotaxic center, mammals, cat |
1 |
|
control of respiration |
1 |
|
cyclic gmp - metabolism |
1 |
|
cytochrome oxidase |
1 |
|
decerebrate state |
1 |
|
decerebrate state - physiopathology |
1 |
|
dendrite |
1 |
|
development |
1 |
|
development, neonatal rat |
1 |
|
dizocilpine |
1 |
|
dizocilpine maleate - pharmacology |
1 |
|
dna-binding proteins - metabolism |
1 |
|
dopamine-β-hydroxylase |
1 |
|
dose-response relationship, drug |
1 |
|
efferent pathways - physiology |
1 |
|
energy deprivation |
1 |
|
epididymis |
1 |
|
eupnea |
1 |
|
evoked potentials |
1 |
|
excitability |
1 |
|
excitatory amino acid antagonists - pharmacology |
1 |
|
extracellular sodium ions |
1 |
|
extracellular vesicles |
1 |
|
fluorescent dyes |
1 |
|
forskolin |
1 |
|
fura-2 |
1 |
|
gasping |
1 |
|
glucose - deficiency |
1 |
|
glutamate receptors |
1 |
|
gs-protein |
1 |
|
gtp-binding protein alpha subunits, gs - metabolism |
1 |
|
heart |
1 |
|
heart - physiopathology |
1 |
|
hippocampal neuron |
1 |
|
hippocampus - cytology - metabolism |
1 |
|
hippocampus - drug effects - metabolism |
1 |
|
hippocampus - metabolism - physiology |
1 |
|
histocytochemistry |
1 |
|
homeostasis |
1 |
|
homeostasis - physiology |
1 |
|
hydrogen-ion concentration |
1 |
|
hypercapnia - blood - physiopathology |
1 |
|
hypercapnia - physiopathology |
1 |
|
hyperoxia - physiopathology |
1 |
|
hypertrophy |
1 |
|
hypoglossal nerve - physiology |
1 |
|
hypoglycemia |
1 |
|
hypoventilation - physiopathology |
1 |
|
hypoxemia |
1 |
|
hypoxia, ventilatory response |
1 |
|
hypoxia-inducible factor 1 |
1 |
|
imidazoles - pharmacology |
1 |
|
immuno-electron microscope |
1 |
|
immunoelectron microscopy |
1 |
|
immunohistochemistry - methods |
1 |
|
inhalation |
1 |
|
inhalation - physiology |
1 |
|
intermittent |
1 |
|
intracellular ca2+ transient |
1 |
|
intracellular calcium ion concentration |
1 |
|
intracellular fluid - chemistry - drug effects |
1 |
|
intracellular ph |
1 |
|
ion channel gating |
1 |
|
ischemia |
1 |
|
ischemia/reperfusion |
1 |
|
kainic acid |
1 |
|
kainic acid - administration & dosage - pharmacology |
1 |
|
kainic acid - pharmacology |
1 |
|
ketamine - pharmacology |
1 |
|
losartan - pharmacology |
1 |
|
mammals, cat |
1 |
|
mammals, cat, control of breathing, rhythm generation |
1 |
|
mediators, nmda |
1 |
|
medulla |
1 |
|
medulla oblongata - cytology - physiology |
1 |
|
medulla oblongata - drug effects - physiology |
1 |
|
medulla oblongata - pathology - physiopathology |
1 |
|
medulla oblongata - physiology |
1 |
|
medulla, pons, pattern of breathing |
1 |
|
medulla, pons, rhythm generation |
1 |
|
medulla, ventrolateral |
1 |
|
melatonin - pharmacology |
1 |
|
mesencephalon - physiology |
1 |
|
metabolic syndrome x - complications - drug therapy - epidemiology |
1 |
|
microelectrodes |
1 |
|
microinjections |
1 |
|
mitochondria |
1 |
|
mk801 |
1 |
|
myocardial contraction - drug effects |
1 |
|
myocardial reperfusion injury - metabolism |
1 |
|
myocytes, cardiac - drug effects - metabolism |
1 |
|
myocytes, cardiac - metabolism |
1 |
|
n-methyl-d-aspartate receptors |
1 |
|
neonatal rat |
1 |
|
nerve fibers - physiology |
1 |
|
nerve fibers - physiology - ultrastructure |
1 |
|
neurobiotin |
1 |
|
neurokinin 1 receptor |
1 |
|
neuronal activity, medulla |
1 |
|
neurons - cytology - metabolism |
1 |
|
neurons - drug effects - metabolism |
1 |
|
neurons - drug effects - physiology |
1 |
|
neurons - physiology |
1 |
|
neurons - physiology - ultrastructure |
1 |
|
nitric oxide - biosynthesis |
1 |
|
nitric oxide - pharmacology |
1 |
|
nitric oxide synthase - antagonists & inhibitors |
1 |
|
nitric oxide synthase - biosynthesis |
1 |
|
nitrogen - metabolism |
1 |
|
no |
1 |
|
no synthase |
1 |
|
nuclear proteins - metabolism |
1 |
|
obstructive sleep apnea |
1 |
|
obstructive sleep apnea hypopnea syndrome |
1 |
|
osa |
1 |
|
osmolar concentration |
1 |
|
oxygen deprivation |
1 |
|
oxygen sensor |
1 |
|
pancreas |
1 |
|
pancreas - physiopathology |
1 |
|
patch clamp |
1 |
|
pattern of breathing, gasping |
1 |
|
pattern of breathing, inspiratory off-switch |
1 |
|
pharmacologica agents, cnqx, dnqx, kainic acid, nmda agonists, mk-801, ap-5 |
1 |
|
pharynx - innervation - physiology |
1 |
|
pharynx - physiology |
1 |
|
phrenic nerve - drug effects - physiology |
1 |
|
phrenic nerve - physiology |
1 |
|
physical stimulation |
1 |
|
pneumotaxic center |
1 |
|
pneumotaxic center, various functions |
1 |
|
polyamines - pharmacology |
1 |
|
pons - anatomy & histology - physiology |
1 |
|
pons - cytology - drug effects - physiology |
1 |
|
pons - metabolism |
1 |
|
pons - physiology |
1 |
|
pontine reticular formation |
1 |
|
postsynaptic |
1 |
|
potassium channel |
1 |
|
potassium channels |
1 |
|
protein kinase c |
1 |
|
proteomics |
1 |
|
protons |
1 |
|
pulmonary alveoli - chemistry - physiology |
1 |
|
purinergic receptor |
1 |
|
pyridines - pharmacology |
1 |
|
quinoxalines - pharmacology |
1 |
|
ras |
1 |
|
rat |
1 |
|
receptor cross-talk - physiology |
1 |
|
receptor, angiotensin, type 1 |
1 |
|
receptor, angiotensin, type 2 |
1 |
|
receptors, adrenergic, beta - physiology |
1 |
|
receptors, angiotensin - analysis - genetics |
1 |
|
receptors, angiotensin - metabolism |
1 |
|
receptors, endothelin - metabolism |
1 |
|
receptors, n-methyl-d-aspartate - physiology |
1 |
|
receptors, nmda, pons |
1 |
|
receptors, opioid, kappa - genetics - metabolism |
1 |
|
receptors, opioid, kappa - physiology |
1 |
|
receptors, vascular endothelial growth factor - metabolism |
1 |
|
recruitment, neurophysiological |
1 |
|
reflex |
1 |
|
reflex - physiology |
1 |
|
reflex, aspiration, medullary neurons |
1 |
|
reflexes, aspiration |
1 |
|
rem sleep |
1 |
|
renin-angiotensin system |
1 |
|
renin-angiotensin system - genetics - physiology |
1 |
|
respiration - drug effects - physiology |
1 |
|
respiration - physiology |
1 |
|
respiration disorders - pathology - physiopathology |
1 |
|
respiratory center - anatomy & histology - physiology |
1 |
|
respiratory center - physiology |
1 |
|
respiratory mechanics - physiology |
1 |
|
respiratory neurons, pons, inspiratory termination |
1 |
|
rhythm generator, co2 sensitivity |
1 |
|
rhythm, respiratory, generation |
1 |
|
risk factors |
1 |
|
ryanodine receptor |
1 |
|
ryanodine receptor calcium release channel - biosynthesis - drug effects |
1 |
|
s-nitrosothiols - metabolism |
1 |
|
s-nitrosylation |
1 |
|
sarcoplasmic reticulum |
1 |
|
sarcoplasmic reticulum - metabolism |
1 |
|
sarcoplasmic reticulum calcium-transporting atpases |
1 |
|
serum |
1 |
|
sodium |
1 |
|
sodium - metabolism |
1 |
|
sodium channel |
1 |
|
sodium channels - drug effects - metabolism - physiology |
1 |
|
sodium-calcium exchanger - metabolism |
1 |
|
sodium/calcium exchange |
1 |
|
species specificity |
1 |
|
spectrometry, fluorescence |
1 |
|
synapse |
1 |
|
tetradecanoylphorbol acetate - pharmacology |
1 |
|
tetrodotoxin |
1 |
|
tetrodotoxin - pharmacology |
1 |
|
tissue culture techniques |
1 |
|
transcription factors |
1 |
|
type i cells |
1 |
|
ultrastructure.chronic |
1 |
|
vagi |
1 |
|
vagotomy |
1 |
|
vagus nerve - physiology |
1 |
|
ventilation, hypercapnic response |
1 |
|
voltage-gated calcium currents |
1 |
|
voltage-gated na+ channel |
1 |
|
β-adrenoceptor |
1 |
|
β-adrenoceptor receptors |
1 |
|
κ-opioid receptor |
1 |
|
化学感受器 |
1 |
|
病理生理 |
1 |
|
颈动脉体 |
1 |
